Adaptin Bio (APTN) Assets Average (2023 - 2026)

Adaptin Bio (APTN) has 4 years of Assets Average data on file, last reported at $662638.0 in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 57.16% year-over-year to $662638.0; the trailing twelve-month figure through Mar 2026 stood at $662638.0 (down 57.16% YoY), and the FY2025 full-year result was $429287.0, up 258.04% from the prior year.
• Assets Average retreated to $662638.0 in Q1 2026, from $799316.5 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.3 million in Q2 2025 to a low of $322.0 in Q3 2024.
• A 4-year average of $609980.0 and a median of $119868.5 in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average surged 643295.87% in 2025 and slumped 57.16% in 2026, its largest moves.
• Tracing APTN's Assets Average over 4 years: stood at $380.0 in 2023, then jumped by 31444.34% to $119868.5 in 2024, then surged by 566.83% to $799316.5 in 2025, then slipped by 17.1% to $662638.0 in 2026.
• Business Quant data shows APTN's Assets Average at $662638.0 in Q1 2026, $799316.5 in Q4 2025, and $1.3 million in Q3 2025.